Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
Paolo Milani, Amedeo Massacesi, Stefano Ciaccia, Marco Setaccioli, Stefania Moschini, Fulvio BergaminiDipartimento di Oculistica, Istituto Auxologico Italiano, Milano, ItalyBackground: The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed ba...
Saved in:
Main Authors: | Bergamini F, Moschini S, Setaccioli M, Ciaccia S, Massacesi A, Milani P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/8853ba05e850495e89b7caf57fc51a6f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
by: Milani P, et al.
Published: (2016) -
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
by: Palejwala NV, et al.
Published: (2014)